3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide

C21H20ClN5O3S — CID 55967562

IUPAC3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide
SMILESCN1CCCC1=NS(=O)(=O)c1ccc(NC(=O)C=Cc2c(Cl)nc3ccccn23)cc1
InChIInChI=1S/C21H20ClN5O3S/c1-26-13-4-6-19(26)25-31(29,30)16-9-7-15(8-10-16)23-20(28)12-11-17-21(22)24-18-5-2-3-14-27(17)18/h2-3,5,7-12,14H,4,6,13H2,1H3,(H,23,28)
InChIKeyFOQWYJGXLZHKKQ-UHFFFAOYSA-N
MW457.94 g/mol
LogP3.45
Rot. Bonds5

About 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide

3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide (PubChem CID 55967562) has the molecular formula C21H20ClN5O3S and a molecular weight of 457.94 g/mol. Its IUPAC name is 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide.

Molecular Properties

Compound Name3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide
PubChem CID55967562
Molecular FormulaC21H20ClN5O3S
Molecular Weight457.94 g/mol
Exact Mass457.10
IUPAC Name3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide
SMILESCN1CCCC1=NS(=O)(=O)c1ccc(NC(=O)C=Cc2c(Cl)nc3ccccn23)cc1
InChIInChI=1S/C21H20ClN5O3S/c1-26-13-4-6-19(26)25-31(29,30)16-9-7-15(8-10-16)23-20(28)12-11-17-21(22)24-18-5-2-3-14-27(17)18/h2-3,5,7-12,14H,4,6,13H2,1H3,(H,23,28)
InChIKeyFOQWYJGXLZHKKQ-UHFFFAOYSA-N
XLogP3.45
TPSA96.14 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500457.94
LogP ≤ 53.45
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide?
The IUPAC name of 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide (CID 55967562) is 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide.
What is the SMILES notation for 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide?
The canonical SMILES for 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide is CN1CCCC1=NS(=O)(=O)c1ccc(NC(=O)C=Cc2c(Cl)nc3ccccn23)cc1.
What is the InChIKey of 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide?
The InChIKey is FOQWYJGXLZHKKQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H20ClN5O3S/c1-26-13-4-6-19(26)25-31(29,30)16-9-7-15(8-10-16)23-20(28)12-11-17-21(22)24-18-5-2-3-14-27(17)18/h2-3,5,7-12,14H,4,6,13H2,1H3,(H,23,28).
What are the key properties of 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide?
3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide has a molecular weight of 457.94 g/mol, XLogP of 3.45, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-[4-[(1-methylpyrrolidin-2-ylidene)amino]sulfonylphenyl]prop-2-enamide is sourced from PubChem (CID 55967562), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).